• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 10621
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Cardiac Arrest (1762); Ischemia (1942)
Event Date 11/23/2021
Event Type  Death  
Event Description
It was reported that patient death occurred.The patient presented with st elevation myocardial infarction.Vascular access was obtained via the femoral artery.The 90% stenosed, 2.75 x 28mm, de novo target lesion was located in the mildly tortuous and moderately calcified left anterior descending artery.Following pre-dilation, the 2.75 x 28 synergy stent was implanted.The patient went into slow flow, no re-flow, and cardiogenic shock.Cardiopulmonary resuscitation was attempted but the patient could not be revived and died on the table.
 
Event Description
It was reported that patient death occurred.The patient presented with st elevation myocardial infarction.Vascular access was obtained via the femoral artery.The 90% stenosed, 2.75 x 28mm, de novo target lesion was located in the mildly tortuous and moderately calcified left anterior descending artery.Following pre-dilation, the 2.75 x 28 synergy stent was implanted.The patient went into slow flow, no re-flow, and cardiogenic shock.Cardiopulmonary resuscitation was attempted but the patient could not be revived and died on the table.It was further reported that there was no issue with stent deployment; the stent was deployed at 11 atm and the balloon inflated well.The stent was post dilated at 12 atm with a 2.75 x 9 balloon.The physician considered cause of the death to be slow flow.The patient had the history of acute coronary syndrome (acs).An autopsy was not performed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key12910309
MDR Text Key281525551
Report Number2134265-2021-15131
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeIN
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 12/07/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/01/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/27/2023
Device Model Number10621
Device Catalogue Number10621
Device Lot Number0027278961
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/07/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/27/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
-
-